Association of the putative susceptibility gene, transient receptor potential protein melastatin type 2, with bipolar disorder
- PMID: 16252251
- DOI: 10.1002/ajmg.b.30239
Association of the putative susceptibility gene, transient receptor potential protein melastatin type 2, with bipolar disorder
Abstract
Disturbed intracellular calcium (Ca(2+)) homeostasis has been implicated in bipolar disorder (BD). Reduced mRNA levels of the transient receptor potential Ca(2+) permeable channel melastatin type 2, TRPM2, in B lymphoblast cell lines (BLCL) from bipolar I disorder (BD-I) patients showing elevated basal intracellular Ca(2+) ([Ca(2+)](B)), an index of altered intracellular Ca(2+) homeostasis, along with its location within a putative BD susceptibility locus (21q22.3), implicates the involvement of this gene in the Ca(2+) abnormalities and the genetic diathesis to BD. We tested this hypothesis by examining the association of selected single nucleotide polymorphisms (SNPs) and their haplotypes, spanning the TRPM2 gene, with BD and BLCL [Ca(2+)](B), in a case control design. The 5' TaqMan SNP assay was used to detect selected SNPs. BLCL [Ca(2+)](B) was determined by ratiometric fluorometry. SNP rs1618355 in intron 18 was significantly associated with BD as a whole (P < 7.0 x 10(-5); odds ratio (OR) = 2.60), and when stratified into BD-I (P < 7.0 x 10(-5), OR = 2.48) and BD-II (P = 7.0 x 10(-5), OR = 2.88) subgroups. In addition, the alleles of the individual SNPs forming a seven marker at-risk haplotype were in excess in BD (12.0% in BD vs. 0.9% in controls; P = 2.3 x 10(-12)). A weak relationship was also detected between BLCL [Ca(2+)](B) and TRPM2 SNP rs1612472 in intron 19. These findings suggest genetic variants of the TRPM2 gene increase risk for BD and support the notion that TRPM2 may be involved in the pathophysiology of BD.
(c) 2005 Wiley-Liss, Inc.
Similar articles
-
TRPM2 variants and bipolar disorder risk: confirmation in a family-based association study.Bipolar Disord. 2009 Feb;11(1):1-10. doi: 10.1111/j.1399-5618.2008.00655.x. Bipolar Disord. 2009. PMID: 19133961
-
Association of the iPLA2β gene with bipolar disorder and assessment of its interaction with TRPM2 gene polymorphisms.Psychiatr Genet. 2013 Apr;23(2):86-9. doi: 10.1097/YPG.0b013e32835d700d. Psychiatr Genet. 2013. PMID: 23277130
-
Further support for association of the mitochondrial complex I subunit gene NDUFV2 with bipolar disorder.Bipolar Disord. 2008 Feb;10(1):105-10. doi: 10.1111/j.1399-5618.2008.00535.x. Bipolar Disord. 2008. PMID: 18199248
-
CACNA1C SNP rs1006737 associates with bipolar I disorder independent of the Bcl-2 SNP rs956572 variant and its associated effect on intracellular calcium homeostasis.World J Biol Psychiatry. 2016 Oct;17(7):525-34. doi: 10.3109/15622975.2015.1019360. Epub 2015 Apr 5. World J Biol Psychiatry. 2016. PMID: 25843436
-
Fine mapping of a susceptibility locus for bipolar and genetically related unipolar affective disorders, to a region containing the C21ORF29 and TRPM2 genes on chromosome 21q22.3.Mol Psychiatry. 2006 Feb;11(2):134-42. doi: 10.1038/sj.mp.4001759. Mol Psychiatry. 2006. PMID: 16205735 Clinical Trial.
Cited by
-
Pharming for Genes in Neurotransmission: Combining Chemical and Genetic Approaches in Caenorhabditis elegans.ACS Chem Neurosci. 2018 Aug 15;9(8):1963-1974. doi: 10.1021/acschemneuro.7b00509. Epub 2018 Mar 6. ACS Chem Neurosci. 2018. PMID: 29432681 Free PMC article. Review.
-
Advances in TRP channel drug discovery: from target validation to clinical studies.Nat Rev Drug Discov. 2022 Jan;21(1):41-59. doi: 10.1038/s41573-021-00268-4. Epub 2021 Sep 15. Nat Rev Drug Discov. 2022. PMID: 34526696 Free PMC article. Review.
-
Transient Receptor Potential-Melastatin Channel Family Member 2: Friend or Foe.Trans Am Clin Climatol Assoc. 2017;128:308-329. Trans Am Clin Climatol Assoc. 2017. PMID: 28790515 Free PMC article. Review.
-
TRPM2 Channel in Microglia as a New Player in Neuroinflammation Associated With a Spectrum of Central Nervous System Pathologies.Front Pharmacol. 2019 Mar 12;10:239. doi: 10.3389/fphar.2019.00239. eCollection 2019. Front Pharmacol. 2019. PMID: 30914955 Free PMC article. Review.
-
TRPM2: a candidate therapeutic target for treating neurological diseases.Acta Pharmacol Sin. 2018 May;39(5):722-732. doi: 10.1038/aps.2018.31. Epub 2018 Apr 19. Acta Pharmacol Sin. 2018. PMID: 29671419 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous